MicardisPlus 80 mg/25 mg tablets
Licence Info section shown.
| Licence number | Strength | ATC Code | Dosage Form |
|---|---|---|---|
| EU/1/02/213/17 | C09DA | Tablet | |
| EU/1/02/213/18 | C09DA | Tablet | |
| EU/1/02/213/19 | C09DA | Tablet | |
| EU/1/02/213/20 | C09DA | Tablet | |
| EU/1/02/213/21 | C09DA | Tablet | |
| EU/1/02/213/22 | C09DA | Tablet | |
| EU/1/02/213/23 | C09DA | Tablet |
- Licence number
- EU/1/02/213/17
- Strength
- –
- ATC Code
- C09DA
- Dosage Form
- Tablet
- Licence number
- EU/1/02/213/18
- Strength
- –
- ATC Code
- C09DA
- Dosage Form
- Tablet
- Licence number
- EU/1/02/213/19
- Strength
- –
- ATC Code
- C09DA
- Dosage Form
- Tablet
- Licence number
- EU/1/02/213/20
- Strength
- –
- ATC Code
- C09DA
- Dosage Form
- Tablet
- Licence number
- EU/1/02/213/21
- Strength
- –
- ATC Code
- C09DA
- Dosage Form
- Tablet
- Licence number
- EU/1/02/213/22
- Strength
- –
- ATC Code
- C09DA
- Dosage Form
- Tablet
- Licence number
- EU/1/02/213/23
- Strength
- –
- ATC Code
- C09DA
- Dosage Form
- Tablet
Boehringer Ingelheim Limited
The Crescent Building, , Northwood, Santry, Dublin 9